• Median Technologies and U.S. subsidiary eyonis Inc. will present eyonis LCS at the 50th I-ELCAP lung cancer screening conference.
• The conference runs October 22-24, 2026, at the Icahn School of Medicine at Mount Sinai in New York City.
• October 23 presentations will cover AI-powered lung nodule detection and malignancy prediction for large-scale screening programs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Median Technologies SA published the original content used to generate this news brief via Business Wire (Ref. ID: 202610201145BIZWIRE_USPR_____20261020_BW078366) on October 20, 2026, and is solely responsible for the information contained therein.